Dopaminergic medicines used in the treatment of parkinson’s disease: Risk of Dopamine dysregulation syndrome

Dopaminergic medicines used in the treatment of parkinson’s disease: Risk of Dopamine dysregulation syndrome

2020 Oct

Download latest version
Document Number: DHCPL
Version: 1
Date Updated: 22/10/2020
File Type: pdf
Category: Communication To Health Care Professionals
Unit: Pharmacovigilance